Schrödinger announced the appointment of veteran biotech leader Rosana Kapeller, M.D., Ph.D., to its Board of Directors. Dr. Kapeller brings over two decades of biotech leadership experience and is deeply familiar with Schrödinger’s platform, having spent eight years in an executive role at Nimbus Therapeutics, a computation-driven drug discovery company co-founded by Atlas Venture and Schrödinger.